share_log

Johnson & Johnson | DEF 14A: Definitive information statements

Johnson & Johnson | DEF 14A: Definitive information statements

強生 | DEF 14A：股東委託書決議
SEC announcement ·  03/13 19:38
牛牛AI助理已提取核心訊息
Johnson & Johnson (J&J) has announced the filing of its definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) for its upcoming Annual Meeting of Shareholders scheduled for April 25, 2024. The proxy statement details the agenda for the meeting, including the election of 13 director nominees, an advisory vote on executive officer compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2024. Additionally, two shareholder proposals are presented for consideration: one regarding gender-based compensation gaps and associated risks, and another on the impact of extended patent exclusivities on patient access. The Board of Directors has recommended voting against both shareholder proposals. The meeting will be held in a virtual format, and shareholders as of the record date, February 27, 2024, are eligible to vote. The proxy statement and annual report are available online, and shareholders are encouraged to vote in advance using the internet, phone, or mail.
Johnson & Johnson (J&J) has announced the filing of its definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) for its upcoming Annual Meeting of Shareholders scheduled for April 25, 2024. The proxy statement details the agenda for the meeting, including the election of 13 director nominees, an advisory vote on executive officer compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2024. Additionally, two shareholder proposals are presented for consideration: one regarding gender-based compensation gaps and associated risks, and another on the impact of extended patent exclusivities on patient access. The Board of Directors has recommended voting against both shareholder proposals. The meeting will be held in a virtual format, and shareholders as of the record date, February 27, 2024, are eligible to vote. The proxy statement and annual report are available online, and shareholders are encouraged to vote in advance using the internet, phone, or mail.
強生（J&J）宣佈向美國證券交易委員會（SEC）提交定於2024年4月25日舉行的年度股東大會的最終委託書。委託書詳細說明了會議議程，包括選舉13名董事候選人，就執行官薪酬進行諮詢投票，以及批准普華永道會計師事務所爲2024財年的獨立註冊會計師事務所。此外，還有兩項股東提案供審議：一項涉及基於性別的薪酬差距和相關風險，另一項關於延長專利排他性對患者准入的影響。董事會建議對這兩項股東提案投反對票。會議將以虛擬形式舉行，截至記錄日期，即2024年2月27日，股東有資格投票。委託書和年度報告可在線獲取，鼓勵股東提前使用互聯網、電話或郵件進行投票。
強生（J&J）宣佈向美國證券交易委員會（SEC）提交定於2024年4月25日舉行的年度股東大會的最終委託書。委託書詳細說明了會議議程，包括選舉13名董事候選人，就執行官薪酬進行諮詢投票，以及批准普華永道會計師事務所爲2024財年的獨立註冊會計師事務所。此外，還有兩項股東提案供審議：一項涉及基於性別的薪酬差距和相關風險，另一項關於延長專利排他性對患者准入的影響。董事會建議對這兩項股東提案投反對票。會議將以虛擬形式舉行，截至記錄日期，即2024年2月27日，股東有資格投票。委託書和年度報告可在線獲取，鼓勵股東提前使用互聯網、電話或郵件進行投票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。